Artificial Cornea and Corneal Implant Market Size, Share, Trends, Growth and Forecast Report 2021-2027

Description

The global Artificial Cornea and Corneal Implant market garnered revenue around USD 398.63 million in 2020 and projected to reach USD 678.20 million in 2027, with at a compound annual growth rate (CAGR) 8.5% throughout the estimate period from 2021 to 2027. The growth in the artificial cornea implant market is attributed to the willingness of the customer to spend on eye care. Furthermore, increase in prevalence of ophthalmic diseases, such as keratoconus, Fuchs dystrophy, and infectious keratitis, is the key factor that propels the market growth. Apart from this, increase in healthcare expenditure on eye care in the developing countries boosts the growth of the global artificial cornea implant market. In addition, factors such as increase in number of surgeries and rise in demand for new techniques for the treatment provides growth opportunities for the market. However, high cost associated with cornea implant surgeries poses a threat toward the growth of the global artificial cornea implant market. In addition, side effects of the cornea surgeries prevents mass adoption of cornea implant.

This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.

The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Artificial Cornea and Corneal Implant market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Artificial Cornea and Corneal Implant market growth.

The global Artificial Cornea and Corneal Implant market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.

Major manufacturers analysed under this study comprises:

The report provides a comprehensive analysis of the leading companies operating in the market are AJL Ophthalmic, CorneaGen Inc., CorNeat Vision, LinkoCare Life Sciences AB, Presbia plc, Mediphacos, Aurolab, Cornea Biosciences, DIOPTEX GmbH, and EyeYon Medical.

This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:

By Type

·         Human Cornea

·         Artificial Cornea 

By Transplant Type

·         Penetrating Keratoplasty

·         Endothelial Keratoplasty

·         Anterior lamellar keratoplasty

·         keratoprosthesis

By Disease Indication

·         Fuchs' Dystrophy

·         Fungal Keratitis

·         Keratoconus

·         Others

By End User

·         Hospitals & Ambulatory Surgical Centers

·         Specialty Clinics

Regional Analysis and Forecast

Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope:

 

  • North America
  • United States
  • Canada
  •  
  • Europe
  • Germany
  • United Kingdom
  • Italy
  • France
  • Rest of EU
  •  
  • Asia Pacific
  • China
  • India
  • Japan
  • Southeast Asia
  • Rest of APAC
  •  
  • Central & South America 
  • Brazil 
  • Argentina
  • Rest of Central & South America 
  •  
  • Middle East and Africa
  • GCC
  • North Africa
  • South Africa

TABLE OF CONTENT

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Artificial Cornea and Corneal Implant Market, By Type

7.1.  Artificial Cornea and Corneal Implant Market, by Type, 2020-2027

7.1.1.    Human Cornea

7.1.1.1.        Market Revenue and Forecast (2016-2027)

7.1.2.    Artificial Cornea

7.1.2.1.        Market Revenue and Forecast (2016-2027)

Chapter 8.  Global Artificial Cornea and Corneal Implant Market, By Transplant Type

8.1.  Artificial Cornea and Corneal Implant Market, by Transplant Type, 2020-2027

8.1.1.    Penetrating Keratoplasty

8.1.1.1.        Market Revenue and Forecast (2016-2027)

8.1.2.    Endothelial Keratoplasty

8.1.2.1.        Market Revenue and Forecast (2016-2027)

8.1.3.    Anterior lamellar keratoplasty

8.1.3.1.        Market Revenue and Forecast (2016-2027)

8.1.4.    keratoprosthesis

8.1.4.1.        Market Revenue and Forecast (2016-2027)

Chapter 9.  Global Artificial Cornea and Corneal Implant Market, By End User

9.1.  Artificial Cornea and Corneal Implant Market, by End User, 2020-2027

9.1.1.    Fuchs' Dystrophy

9.1.1.1.        Market Revenue and Forecast (2016-2027)

9.1.2.    Fungal Keratitis

9.1.2.1.        Market Revenue and Forecast (2016-2027)

9.1.3.    Keratoconus

9.1.3.1.        Market Revenue and Forecast (2016-2027)

9.1.4.    Others

9.1.4.1.        Market Revenue and Forecast (2016-2027)

Chapter 10.      Global Artificial Cornea and Corneal Implant Market, By Capacitor

10.1.        Artificial Cornea and Corneal Implant Market, by Capacitor, 2020-2027

10.1.1.  Hospitals & Ambulatory Surgical Centers

10.1.1.1.      Market Revenue and Forecast (2016-2027)

10.1.2.  Specialty Clinics

10.1.2.1.      Market Revenue and Forecast (2016-2027)

Chapter 11.      Global Artificial Cornea and Corneal Implant Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Type (2016-2027)

11.1.2.  Market Revenue and Forecast, by Transplant Type (2016-2027)

11.1.3.  Market Revenue and Forecast, by End User (2016-2027)

11.1.4.  Market Revenue and Forecast, by Capacitor (2016-2027)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Type (2016-2027)

11.1.5.2.      Market Revenue and Forecast, by Transplant Type (2016-2027)

11.1.5.3.      Market Revenue and Forecast, by End User (2016-2027)

11.1.5.4.      Market Revenue and Forecast, by Capacitor (2016-2027)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Type (2016-2027)

11.1.6.2.      Market Revenue and Forecast, by Transplant Type (2016-2027)

11.1.6.3.      Market Revenue and Forecast, by End User (2016-2027)

11.1.6.4.      Market Revenue and Forecast, by Capacitor (2016-2027)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Type (2016-2027)

11.2.2.  Market Revenue and Forecast, by Transplant Type (2016-2027)

11.2.3.  Market Revenue and Forecast, by End User (2016-2027)

11.2.4.  Market Revenue and Forecast, by Capacitor (2016-2027)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Type (2016-2027)

11.2.5.2.      Market Revenue and Forecast, by Transplant Type (2016-2027)

11.2.5.3.      Market Revenue and Forecast, by End User (2016-2027)

11.2.5.4.      Market Revenue and Forecast, by Capacitor (2016-2027)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Type(2016-2027)

11.2.6.2.      Market Revenue and Forecast, by Transplant Type (2016-2027)

11.2.6.3.      Market Revenue and Forecast, by End User (2016-2027)

11.2.6.4.      Market Revenue and Forecast, by Capacitor (2016-2027)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Type (2016-2027)

11.2.7.2.      Market Revenue and Forecast, by Transplant Type (2016-2027)

11.2.7.3.      Market Revenue and Forecast, by End User (2016-2027)

11.2.7.4.      Market Revenue and Forecast, by Capacitor (2016-2027)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Type (2016-2027)

11.2.8.2.      Market Revenue and Forecast, by Transplant Type (2016-2027)

11.2.8.3.      Market Revenue and Forecast, by End User (2016-2027)

11.2.8.4.      Market Revenue and Forecast, by Capacitor (2016-2027)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Type (2016-2027)

11.3.2.  Market Revenue and Forecast, by Transplant Type (2016-2027)

11.3.3.  Market Revenue and Forecast, by End User (2016-2027)

11.3.4.  Market Revenue and Forecast, by Capacitor (2016-2027)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Type (2016-2027)

11.3.5.2.      Market Revenue and Forecast, by Transplant Type (2016-2027)

11.3.5.3.      Market Revenue and Forecast, by End User (2016-2027)

11.3.5.4.      Market Revenue and Forecast, by Capacitor (2016-2027)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Type (2016-2027)

11.3.6.2.      Market Revenue and Forecast, by Transplant Type (2016-2027)

11.3.6.3.      Market Revenue and Forecast, by End User (2016-2027)

11.3.6.4.      Market Revenue and Forecast, by Capacitor (2016-2027)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Type (2016-2027)

11.3.7.2.      Market Revenue and Forecast, by Transplant Type (2016-2027)

11.3.7.3.      Market Revenue and Forecast, by End User (2016-2027)

11.3.7.4.      Market Revenue and Forecast, by Capacitor (2016-2027)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Type (2016-2027)

11.3.8.2.      Market Revenue and Forecast, by Transplant Type (2016-2027)

11.3.8.3.      Market Revenue and Forecast, by End User (2016-2027)

11.3.8.4.      Market Revenue and Forecast, by Capacitor (2016-2027)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Type (2016-2027)

11.4.2.  Market Revenue and Forecast, by Transplant Type (2016-2027)

11.4.3.  Market Revenue and Forecast, by End User (2016-2027)

11.4.4.  Market Revenue and Forecast, by Capacitor (2016-2027)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Type (2016-2027)

11.4.5.2.      Market Revenue and Forecast, by Transplant Type (2016-2027)

11.4.5.3.      Market Revenue and Forecast, by End User (2016-2027)

11.4.5.4.      Market Revenue and Forecast, by Capacitor (2016-2027)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Type (2016-2027)

11.4.6.2.      Market Revenue and Forecast, by Transplant Type (2016-2027)

11.4.6.3.      Market Revenue and Forecast, by End User (2016-2027)

11.4.6.4.      Market Revenue and Forecast, by Capacitor (2016-2027)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Type (2016-2027)

11.4.7.2.      Market Revenue and Forecast, by Transplant Type (2016-2027)

11.4.7.3.      Market Revenue and Forecast, by End User (2016-2027)

11.4.7.4.      Market Revenue and Forecast, by Capacitor (2016-2027)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Type (2016-2027)

11.4.8.2.      Market Revenue and Forecast, by Transplant Type (2016-2027)

11.4.8.3.      Market Revenue and Forecast, by End User (2016-2027)

11.4.8.4.      Market Revenue and Forecast, by Capacitor (2016-2027)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Type (2016-2027)

11.5.2.  Market Revenue and Forecast, by Transplant Type (2016-2027)

11.5.3.  Market Revenue and Forecast, by End User (2016-2027)

11.5.4.  Market Revenue and Forecast, by Capacitor (2016-2027)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Type (2016-2027)

11.5.5.2.      Market Revenue and Forecast, by Transplant Type (2016-2027)

11.5.5.3.      Market Revenue and Forecast, by End User (2016-2027)

11.5.5.4.      Market Revenue and Forecast, by Capacitor (2016-2027)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Type (2016-2027)

11.5.6.2.      Market Revenue and Forecast, by Transplant Type (2016-2027)

11.5.6.3.      Market Revenue and Forecast, by End User (2016-2027)

11.5.6.4.      Market Revenue and Forecast, by Capacitor (2016-2027)

Chapter 12.  Company Profiles

12.1.              AJL Ophthalmic

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              CorneaGen Inc.

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              CorNeat Vision

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              LinkoCare Life Sciences AB

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Presbia plc

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Mediphacos

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              Aurolab

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Cornea Biosciences

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              DIOPTEX GmbH

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           EyeYon Medical.

12.10.1.               Company Overview

12.10.2.               Product Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

14.2.              Glossary of Terms

Choose License Type

Checkout Inquiry Sample